I'rom Group Co., Ltd.

TSE:2372 Stock Report

Market Cap: JP¥33.7b

I'rom Group Past Earnings Performance

Past criteria checks 1/6

I'rom Group has been growing earnings at an average annual rate of 4.9%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 12.4% per year. I'rom Group's return on equity is 2%, and it has net margins of 1.4%.

Key information

4.9%

Earnings growth rate

4.4%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate12.4%
Return on equity2.0%
Net Margin1.4%
Next Earnings Update07 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How I'rom Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:2372 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2417,8922586,084577
30 Jun 2417,6978156,039606
31 Mar 2417,7401,4155,688682
31 Dec 2317,3231,2765,558885
30 Sep 2317,3901,6515,246730
30 Jun 2318,2182,3664,915940
31 Mar 2318,3512,5424,708859
31 Dec 2217,9132,4214,1501,077
30 Sep 2218,4933,2214,594635
30 Jun 2217,0972,7704,151682
31 Mar 2215,6931,9614,126582
31 Dec 2115,1002,1154,2660
30 Sep 2114,6671,7773,591318
30 Jun 2114,0851,5803,6370
31 Mar 2112,9061,3733,3600
31 Dec 2012,7971,7543,1660
30 Sep 2010,9611,2823,0270
30 Jun 2010,3921,1163,0490
31 Mar 2010,5931,2363,0530
31 Dec 199,9027433,176-139
30 Sep 1910,5266463,0800
30 Jun 1910,7009182,9700
31 Mar 1910,5789122,8340
31 Dec 1810,3847882,75050
30 Sep 189,4598572,715-59
30 Jun 189,2224892,6290
31 Mar 188,6211,5582,4390
31 Dec 178,1091,8732,257-10
30 Sep 176,9491,6601,985-2
30 Jun 175,6401,6061,7080
31 Mar 174,8902041,5870
31 Dec 164,384-1061,377-14
30 Sep 164,246-3261,517-11
30 Jun 164,148-8251,8930
31 Mar 164,114-8681,9650
31 Dec 154,164-9602,150-14
30 Sep 153,988-1,0901,967-8
30 Jun 153,890-8841,6250
31 Mar 154,134-6061,5660
31 Dec 143,747-6761,559127
30 Sep 143,922-4881,55480
30 Jun 144,277-2441,5170
31 Mar 144,011-2941,4070
31 Dec 134,172-11,2380

Quality Earnings: 2372 has a large one-off gain of ¥391.0M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 2372's current net profit margins (1.4%) are lower than last year (9.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2372's earnings have grown by 4.9% per year over the past 5 years.

Accelerating Growth: 2372's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 2372 had negative earnings growth (-84.4%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).

Return on Equity

High ROE: 2372's Return on Equity (2%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

I'rom Group Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.